Twitter

Novartis Foundation Welcomes Vas Narasimhan to Board of Trustees

Dr. Vas Narasimhan

The Novartis Foundation (No. 2 on the DiversityInc Top 50 Companies list) announced on March 23 that Vasant (Vas) Narasimhan, M.D., joined its Board of Trustees in January. He replaces Rainer Boehm, who stepped down from the Board upon his retirement as Chief Commercial and Medical Affairs Officer for Novartis Pharma AG.

Dr. Narasimhan has been Global Head of Drug Development and Chief Medical Officer for Novartis since February 1, 2016, and is a member of the Executive Committee of Novartis. He brings to the Foundation a wide range of leadership experience in Novartis development and commercial functions, spanning general medicines, oncology, biosimilars and vaccines. Before joining Novartis in 2005, he worked extensively on global public health issues, including HIV/AIDS treatment, multi-drug resistant tuberculosis, and public health policy.

Dr. Narasimhan earned his medical degree from Harvard Medical School, a master’s degree in public policy from Harvard’s John F. Kennedy School of Government and a bachelor’s degree in biological sciences from the University of Chicago, all in the US. He is also an elected member of the (US) National Academy of Medicine.

“I am very excited to have Vas Narasimhan join us on the Board,” says Ann Aerts, Head of the Novartis Foundation. “At the Novartis Foundation, we strive to have unparalleled impact on the health of low- to middle-income communities through a combination of programmatic work, outcomes research, and its translation into policy to tackle emerging global health challenges. We have much to gain from Dr. Narasimhan’s leadership in both global health and in drug development at Novartis, particularly the unprecedented rise and risk of non-communicable diseases and evolving ways to address them.”

Vas Narasimhan welcomes the new opportunity: “I share the foundation’s commitment to innovation in healthcare delivery. Advances in medicine and public health too often leave the poorest populations behind. Bridging interventions in public health, healthcare systems and clinical practice, the Novartis Foundation is uniquely positioned to reach the most underserved patients together with its local and global partners. I look forward to supporting its efforts to have a transformational impact on people’s lives, no matter where they live.”

The Novartis Foundation thanks outgoing Board member Rainer Boehm for his contributions as part of the Novartis Foundation Board of Trustees over the past two years and wishes him a happy and long retirement.

Latest News

Georgia Power Invites Georgians to Say ‘Thank You’ to Employees During Thank a Lineman Month

Originally published on southerncompany.com. For the eighth year in a row, Georgia Power and other electric utilities in Georgia are celebrating and thanking utility workers across the state. The daily work done by linemen in Georgia’s communities is always recognized, but their work is especially pronounced during today’s challenges from the escalating COVID-19 pandemic…

Mastercard: Learning @ Home with Girls4Tech™ Connect

Originally published on newsroom.mastercard.com. Mastercard Provides Free Online STEM Lessons to Children, Teachers and Parents Mastercard extended access to its signature STEM curriculum, Girls4Tech™, through a suite of new online, creative educational resources. The program has been designed to help parents and teachers engage and inspire kids, ages 8-12. Through…

ADP Preparedness Toolkit

Originally posted on ADP LinkedIn Find FAQs, checklists, webcasts, and the resources to help you protect and manage your workforce in the ADP Coronavirus Disease (COVID-19) Employer Preparedness Toolkit: https://bit.ly/2xuM2jW

feinstein, northwell

Northwell Health’s Feinstein Institutes Teams Up with Sanofi, Regeneron Pharmaceuticals, Gilead Sciences to Test COVID-19 Treatments

The research arm of Northwell Health (No. 2 on DiversityInc’s 2019 Top Hospitals & Health Systems), the Feinstein Institutes for Medical Research, is partnering with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi (No. 31 on DiversityInc’s 2019 Top 50 Companies for Diversity) to identify treatments for people hospitalized with moderate to severe…

EY Named a Leader in Managed Security Services and Professional Security Services in Asia-Pacific in Two Studies by IDC

Originally posted on EY.com EY is a leader in Asia-Pacific professional security services among 17 vendors EY has been recognized by IDC as a leader in two of its studies: IDC MarketScape: Asia/Pacific Managed Security Services 2020 Vendor Assessment, and IDC MarketScape: Asia/Pacific Professional Security Services – Advisory, Assessment, and Awareness 2020…

March 2020 ADP National Employment Report®, ADP Small Business Report® and ADP National Franchise Report® to be Released on Wednesday, April 1, 2020

Originally posted on ADP.com : ADP Research Institute® will release the March findings of the ADP National Employment Report, ADP Small Business Report and ADP National Franchise Report on Wednesday, April 1, 2020 at 8:15 a.m. ET. Due to the important contribution that small businesses make to economic growth, ADP Research Institute issues the ADP Small Business Report independently of the ADP National Employment Report. …